Arquivamento - Art. 36 §1° da LPI
#11.2
04/13/2021
RPI 2623
Back to search
Official data from INPI
ADENOVIRUS IMUNOGÊNICO
ArquivadaInvention PatentPCT · US2013024506
Application data
Number
112014019049Type
Invention Patent
Filing
02/01/2013
Publication
07/04/2017
PCT
US2013024506 Progress at the INPI
- Filing02/01/13
- Publication07/04/17
- Abandoned
- Allowance
- Grant
- In force
The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 04/13/2021. We update with every new RPI gazette, published weekly.
Applicants and inventors
Applicants
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
US
Inventors
C. G. (pessoa física)
US
H. J. (pessoa física)
US
J. F. (pessoa física)
US
V. K. (pessoa física)
US
W. Y. (pessoa física)
US
Technical data
IPC Classification
Priority claims
US
61/594,005 · 02/02/2012
Abstract
ABSTRACT[0089] The present invention is directed to immunogenically enhanced adenoviruses for use in cancer therapy and methods for using such viruses.------------------------------------------------------------------------------------------------------------Tradução do ResumoRESUMOPatente de Invenção: "ADENOVIRUS IMUNOGÊNICO".A presente invenção refere-se aos adenovirus imunogeni-camente intensificados para uso em terapia de câncer e métodos para usar tais vírus.
Prosecution history
Publications in the Brazilian Industrial Property Gazette (RPI).
Exigência preliminar
#6.21
12/29/2020
RPI 2608
Não anuência — art. 229 da LPI
#7.5
09/29/2020
RPI 2595
Ciência (anuência ANVISA - art. 229-C)
#7.4
09/17/2019
RPI 2541
Notificação de acesso ao patrimônio genético
#6.6.1
03/27/2018
RPI 2464
Notificação de entrada na fase nacional - PCT
#1.3
07/04/2017
RPI 2426
Alteração de dados cadastrais
#1.1
08/26/2014
RPI 2277
Related
From the same holder
Same category
Patent monitoring
Track this patent in real time.
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.